methylprednisolone and Cancer, Second Primary

methylprednisolone has been researched along with Cancer, Second Primary in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (44.44)	18.2507
2000's	3 (33.33)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ansari, M; Bieri, S; Chalandon, Y; Chapuis, B; Helg, C; Huguet, S; Miralbell, R; Ozsahin, H; Passweg, J; Roosnek, E; Trombetti, A	1
Suzuki, K	1
Castelli, R; Cortelezzi, A; Cro, L; Gianelli, U; Grimoldi, MG; Molteni, M	1
Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M	1
Michaeli, J; Polliack, A; Popovtzer, MM; Ras, E; Rosenmann, E; Shouval, D	1
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA	1
Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L	1
Born, G; Froschauer, R; Gralka, S; Hohenberger, W; Köckerling, F; Müller, V; Ott, R; Reck, T	1
Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D	1

Reviews

1 review(s) available for methylprednisolone and Cancer, Second Primary

Article	Year
Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion. Clinical and experimental nephrology, 2012, Volume: 16, Issue:5 Topics: Aged; Amyloidosis; Bence Jones Protein; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulin Light-chain Amyloidosis; Kidney; Lenalidomide; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Renal Insufficiency; Thalidomide	2012

Article

Year

Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.

Clinical and experimental nephrology, 2012, Volume: 16, Issue:5

Topics: Aged; Amyloidosis; Bence Jones Protein; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulin Light-chain Amyloidosis; Kidney; Lenalidomide; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Pyrazines; Renal Insufficiency; Thalidomide

2012

Other Studies

8 other study(ies) available for methylprednisolone and Cancer, Second Primary

Article	Year
Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation. European journal of haematology, 2011, Volume: 87, Issue:2 Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Eye Diseases; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypothyroidism; Immunosuppression Therapy; Infections; Lymphocyte Depletion; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Nervous System Diseases; Retrospective Studies; Risk Factors; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult	2011
Aggressive natural killer cell leukaemia with a complex karyotype: a case report. Annals of hematology, 2006, Volume: 85, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Antigens, CD; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disseminated Intravascular Coagulation; Epstein-Barr Virus Infections; Fatal Outcome; Female; Genome, Viral; Hepacivirus; Hepatitis C; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Killer Cells, Natural; Leukemia; Liver Cirrhosis; Methylprednisolone; Multiple Organ Failure; Neoplasms, Second Primary; Ovarian Neoplasms; Respiratory Distress Syndrome; Vincristine	2006
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide. International journal of hematology, 2006, Volume: 83, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine	2006
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma. Leukemia & lymphoma, 1993, Volume: 10, Issue:3 Topics: Breast Neoplasms; Fatal Outcome; Female; Gene Expression Regulation, Viral; Glomerulonephritis, Membranoproliferative; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immune Complex Diseases; Lymphoma, B-Cell; Methylprednisolone; Middle Aged; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Virus Activation	1993
True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood, 1996, Jun-15, Volume: 87, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine	1996
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone marrow transplantation, 1996, Volume: 18, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine	1996
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen. Transplantation proceedings, 1998, Volume: 30, Issue:4 Topics: Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Monitoring, Immunologic; Neoplasms, Second Primary; Opportunistic Infections; Postoperative Complications; Retrospective Studies	1998
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue. Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:2 Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine	2002